BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 32102154)

  • 1. [Childhood reducing body myopathy caused by FHL1 gene variation in a child].
    Wei CJ; Wang ZX; Chang XZ; Lyu JL; Ge L; Fan YB; Zhang YH; Xiong H
    Zhonghua Er Ke Za Zhi; 2020 Feb; 58(2):147-149. PubMed ID: 32102154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel FHL1 mutation in a family with reducing body myopathy.
    Schreckenbach T; Henn W; Kress W; Roos A; Maschke M; Feiden W; Dillmann U; Schulz JB; Weis J; Claeys KG
    Muscle Nerve; 2013 Jan; 47(1):127-34. PubMed ID: 23169582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reducing body myopathy and other FHL1-related muscular disorders.
    Schessl J; Feldkirchner S; Kubny C; Schoser B
    Semin Pediatr Neurol; 2011 Dec; 18(4):257-63. PubMed ID: 22172421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Dominant C150Y Mutation in FHL1 Induces Structural Alterations in LIM2 Domain Causing Protein Aggregation In Human and Drosophila Indirect Flight Muscles.
    Santhoshkumar R; Preethish-Kumar V; Mangalaparthi KK; Unni S; Padmanabhan B; T S KP; Nongthomba U; Atchayaram N; Narayanappa G
    J Mol Neurosci; 2021 Nov; 71(11):2324-2335. PubMed ID: 33515430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical, histological and genetic characterization of reducing body myopathy caused by mutations in FHL1.
    Schessl J; Taratuto AL; Sewry C; Battini R; Chin SS; Maiti B; Dubrovsky AL; Erro MG; Espada G; Robertella M; Saccoliti M; Olmos P; Bridges LR; Standring P; Hu Y; Zou Y; Swoboda KJ; Scavina M; Goebel HH; Mitchell CA; Flanigan KM; Muntoni F; Bönnemann CG
    Brain; 2009 Feb; 132(Pt 2):452-64. PubMed ID: 19181672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic heterogeneity in British patients with a founder mutation in the FHL1 gene.
    Sarkozy A; Windpassinger C; Hudson J; Dougan CF; Lecky B; Hilton-Jones D; Eagle M; Charlton R; Barresi R; Lochmüller H; Bushby K; Straub V
    Eur J Hum Genet; 2011 Oct; 19(10):1038-44. PubMed ID: 21629301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skeletal muscle biopsy analysis in reducing body myopathy and other FHL1-related disorders.
    Malfatti E; Olivé M; Taratuto AL; Richard P; Brochier G; Bitoun M; Gueneau L; Laforêt P; Stojkovic T; Maisonobe T; Monges S; Lubieniecki F; Vasquez G; Streichenberger N; Lacène E; Saccoliti M; Prudhon B; Alexianu M; Figarella-Branger D; Schessl J; Bonnemann C; Eymard B; Fardeau M; Bonne G; Romero NB
    J Neuropathol Exp Neurol; 2013 Sep; 72(9):833-45. PubMed ID: 23965743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A zebrafish model for FHL1-opathy reveals loss-of-function effects of human FHL1 mutations.
    Keßler M; Kieltsch A; Kayvanpour E; Katus HA; Schoser B; Schessl J; Just S; Rottbauer W
    Neuromuscul Disord; 2018 Jun; 28(6):521-531. PubMed ID: 29735270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exome Sequencing Identified a Splice Site Mutation in FHL1 that Causes Uruguay Syndrome, an X-Linked Disorder With Skeletal Muscle Hypertrophy and Premature Cardiac Death.
    Xue Y; Schoser B; Rao AR; Quadrelli R; Vaglio A; Rupp V; Beichler C; Nelson SF; Schapacher-Tilp G; Windpassinger C; Wilcox WR
    Circ Cardiovasc Genet; 2016 Apr; 9(2):130-5. PubMed ID: 26933038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FHL1-mutated reducing body myopathy.
    Lim KY; Kim HH; Sung JJ; Oh BM; Kim K; Park SH
    Neuropathology; 2020 Apr; 40(2):185-190. PubMed ID: 31803991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consequences of mutations within the C terminus of the FHL1 gene.
    Schoser B; Goebel HH; Janisch I; Quasthoff S; Rother J; Bergmann M; Müller-Felber W; Windpassinger C
    Neurology; 2009 Aug; 73(7):543-51. PubMed ID: 19687455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective muscle involvement in a family affected by a second LIM domain mutation of fhl1: an imaging study using computed tomography.
    Komagamine T; Kawai M; Kokubun N; Miyatake S; Ogata K; Hayashi YK; Nishino I; Hirata K
    J Neurol Sci; 2012 Jul; 318(1-2):163-7. PubMed ID: 22541254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fhl1 W122S causes loss of protein function and late-onset mild myopathy.
    Emmanuele V; Kubota A; Garcia-Diaz B; Garone C; Akman HO; Sánchez-Gutiérrez D; Escudero LM; Kariya S; Homma S; Tanji K; Quinzii CM; Hirano M
    Hum Mol Genet; 2015 Feb; 24(3):714-26. PubMed ID: 25274776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel mutation in FHL1 in a family with X-linked scapuloperoneal myopathy: phenotypic spectrum and structural study of FHL1 mutations.
    Chen DH; Raskind WH; Parson WW; Sonnen JA; Vu T; Zheng Y; Matsushita M; Wolff J; Lipe H; Bird TD
    J Neurol Sci; 2010 Sep; 296(1-2):22-9. PubMed ID: 20633900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FHL1 mutants that cause clinically distinct human myopathies form protein aggregates and impair myoblast differentiation.
    Wilding BR; McGrath MJ; Bonne G; Mitchell CA
    J Cell Sci; 2014 May; 127(Pt 10):2269-81. PubMed ID: 24634512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Muscle MRI in FHL1-linked reducing body myopathy.
    Astrea G; Schessl J; Clement E; Tosetti M; Mercuri E; Rutherford M; Cioni G; Bönnemann CG; Muntoni F; Battini R
    Neuromuscul Disord; 2009 Oct; 19(10):689-91. PubMed ID: 19616434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of FHL1 induces an age-dependent skeletal muscle myopathy associated with myofibrillar and intermyofibrillar disorganization in mice.
    Domenighetti AA; Chu PH; Wu T; Sheikh F; Gokhin DS; Guo LT; Cui Z; Peter AK; Christodoulou DC; Parfenov MG; Gorham JM; Li DY; Banerjee I; Lai X; Witzmann FA; Seidman CE; Seidman JG; Gomes AV; Shelton GD; Lieber RL; Chen J
    Hum Mol Genet; 2014 Jan; 23(1):209-25. PubMed ID: 23975679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 199th ENMC international workshop: FHL1 related myopathies, June 7-9, 2013, Naarden, The Netherlands.
    Bertrand AT; Bönnemann CG; Bonne G;
    Neuromuscul Disord; 2014 May; 24(5):453-62. PubMed ID: 24613424
    [No Abstract]   [Full Text] [Related]  

  • 19. Reducing body myopathy associated with the LIM2 p.(His123Arg) FHL1 variant.
    Darki L; Jalali-Sohi A; Guzman S; Mathew AJ; Bucelli RC; Hurth KM; Beydoun SR
    Clin Neurol Neurosurg; 2021 Aug; 207():106795. PubMed ID: 34273663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FHL1-related myopathy may not be classified by reducing bodies in muscle biopsy.
    Chen T; Lu X; Shi Q; Guo J; Wang H; Wang Q; Yin X; Zhang Y; Pu C; Zhou D
    Neuromuscul Disord; 2020 Feb; 30(2):165-172. PubMed ID: 32001145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.